Murray Stahl's EDIT Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 27,680 shares of Editas Medicine, Inc. (EDIT) worth $89,683, representing 0.00% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in EDIT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 33,050 shares. Largest reduction occurred in Q1 2022, reducing 8,050 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Editas Medicine (EDIT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Editas Medicine (EDIT) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -1,330 | Reduce 4.58% | 27,680 | $3.24 |
| Q1 2026 | -1,330 | Reduce 4.38% | 29,010 | $2.47 |
| Q4 2025 | -1,330 | Reduce 4.20% | 30,340 | $2.05 |
| Q3 2025 | +1,280 | Add 4.21% | 31,670 | $3.47 |
| Q2 2025 | -1,330 | Reduce 4.19% | 30,390 | $2.20 |
| Q4 2024 | +1,330 | Add 4.38% | 31,720 | $1.27 |
| Q3 2024 | -1,330 | Reduce 4.19% | 30,390 | $3.41 |
| Q4 2023 | -1,330 | Reduce 4.02% | 31,720 | $10.13 |
| Q1 2023 | +33,050 | New Buy | 33,050 | $7.25 |
| Q1 2022 | -8,050 | Sold Out | 0 | $0.00 |
| Q3 2021 | +50 | Add 0.62% | 8,050 | $41.12 |
| Q2 2020 | +8,000 | New Buy | 8,000 | $29.62 |
Murray Stahl's Editas Medicine Investment FAQs
Murray Stahl first purchased Editas Medicine, Inc. (EDIT) in Q2 2020, acquiring 8,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Editas Medicine, Inc. (EDIT) for 22 quarters since Q2 2020.
Murray Stahl's largest addition to Editas Medicine, Inc. (EDIT) was in Q1 2023, adding 33,050 shares worth $239,612.
According to the latest 13F filing for Q2 2026, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 27,680 shares of Editas Medicine, Inc. (EDIT), valued at approximately $89,683.
As of the Q2 2026 filing, Editas Medicine, Inc. (EDIT) represents approximately 0.00% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Editas Medicine, Inc. (EDIT) was 33,050 shares, as reported at the end of Q1 2023.